Our study showed that LM50 provides better control over post-breakfast and post-dinner blood glucose and postprandial glycemic excursions in T2DM patients with mild to moderate hyperglycemia who are receiving premixed human insulin, and thus improves the quality of blood glucose control. The gene discussed is INS; the disease is type 2 diabetes mellitus.